Wright Medical Group Price Target Cut to $26.00 by Analysts at BMO Capital Markets (WMGI)

By Samantha Reynolds

Wright Medical Group (NASDAQ:WMGI) had its price target decreased by BMO Capital Markets from $30.00 to $26.00 in a research report report published on Friday, StockTargetPrices.com reports.

Other equities research analysts also recently issued reports about the company. Brean Capital reiterated a buy rating and issued a $38.00 price target on shares of Wright MedicalGroup in a report on Wednesday, September 2nd. Northland Securities restated a buy rating and set a $32.00 price objective on shares of Wright Medical Group in a research note on Wednesday, September 2nd. Zacks upgraded Wright Medical Group from a sell rating to a hold rating in a research report on Wednesday, July 15th. Piper Jaffray restated a hold rating and issued a $27.00 price objective on shares of Wright Medical Group in a report on Wednesday, September 2nd. Finally, Needham & Company LLC reaffirmed a hold rating on shares of Wright Medical Group in a report on Thursday, August 20th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of $31.42.

Advertisement

In other news, insider Kevin D. Cordell sold 1,778 shares of the stock in a transaction that occurred on Wednesday, October 7th. The stock was sold at an average price of $20.37, for a total value of $36,217.86. Following the completion of the transaction, the insider now directly owns 5,924 shares of the company’s stock, valued at approximately $120,671.88. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Lance A. Berry sold 5,146 shares of the stock in a transaction that occurred on Wednesday, October 7th. The stock was sold at an average price of $20.37, for a total value of $104,824.02. Following the completion of the transaction, the chief financial officer now directly owns 57,950 shares of the company’s stock, valued at $1,180,441.50. The disclosure for this sale can be found here.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement